Free Trial
NYSE:QGEN

Qiagen (QGEN) Stock Price, News & Analysis

Qiagen logo
$47.10 +0.14 (+0.30%)
As of 10:11 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Qiagen Stock (NYSE:QGEN)

Advanced

Key Stats

Today's Range
$46.84
$47.12
50-Day Range
$43.85
$51.09
52-Week Range
$37.63
$51.88
Volume
37,739 shs
Average Volume
1.36 million shs
Market Capitalization
$10.47 billion
P/E Ratio
27.79
Dividend Yield
0.53%
Price Target
$49.40
Consensus Rating
Hold

Company Overview

Qiagen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

QGEN MarketRank™: 

Qiagen scored higher than 89% of companies evaluated by MarketBeat, and ranked 111th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Qiagen has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 3 buy ratings, 9 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Qiagen is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Qiagen has only been the subject of 4 research reports in the past 90 days.

  • Read more about Qiagen's stock forecast and price target.
  • Earnings Growth

    Earnings for Qiagen are expected to grow by 8.85% in the coming year, from $2.26 to $2.46 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Qiagen is 27.76, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.34.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Qiagen is 27.76, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.98.

  • Price to Earnings Growth Ratio

    Qiagen has a PEG Ratio of 2.47. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Qiagen has a P/B Ratio of 2.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Qiagen's valuation and earnings.
  • Percentage of Shares Shorted

    3.10% of the float of Qiagen has been sold short.
  • Short Interest Ratio / Days to Cover

    Qiagen has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Qiagen has recently decreased by 0.74%, indicating that investor sentiment is improving.
  • Dividend Yield

    Qiagen has a dividend yield of 0.54%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Qiagen does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Qiagen is 14.79%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Qiagen will have a dividend payout ratio of 10.16% next year. This indicates that Qiagen will be able to sustain or increase its dividend.

  • Read more about Qiagen's dividend.
  • Percentage of Shares Shorted

    3.10% of the float of Qiagen has been sold short.
  • Short Interest Ratio / Days to Cover

    Qiagen has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Qiagen has recently decreased by 0.74%, indicating that investor sentiment is improving.
  • News Sentiment

    Qiagen has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Qiagen this week, compared to 8 articles on an average week.
  • Search Interest

    6 people have searched for QGEN on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Qiagen to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Qiagen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.00% of the stock of Qiagen is held by insiders.

  • Percentage Held by Institutions

    70.00% of the stock of Qiagen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Qiagen's insider trading history.
Receive QGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QGEN Stock News Headlines

REVEALED: Something Big Happening Behind White House Doors
What I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
Qiagen’s Earnings Call: Strong Growth and Optimistic Outlook
See More Headlines

QGEN Stock Analysis - Frequently Asked Questions

Qiagen's stock was trading at $43.2931 at the beginning of the year. Since then, QGEN shares have increased by 8.5% and is now trading at $46.99.

Qiagen N.V. (NYSE:QGEN) issued its earnings results on Tuesday, August, 5th. The company reported $0.60 EPS for the quarter, meeting analysts' consensus estimates of $0.60. Qiagen's revenue for the quarter was up 7.7% compared to the same quarter last year.
Read the conference call transcript
.

Shares of Qiagen split on the morning of Wednesday, January 29th 2025.The 36-35 split was announced on Wednesday, January 22nd 2025. The newly created shares were distributed to shareholders after the market closes on Tuesday, January 28th 2025. An investor that had 100 shares of stock prior to the split would have 103 shares after the split.

Top institutional shareholders of Qiagen include GAMMA Investing LLC.

Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Qiagen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and PayPal (PYPL).

Company Calendar

Record date for 7/10 Dividend
7/02/2025
Ex-Dividend for 7/10 Dividend
7/02/2025
Dividend Payable
7/10/2025
Last Earnings
8/05/2025
Today
10/07/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:QGEN
CIK
1015820
Employees
5,765
Year Founded
1984

Price Target and Rating

High Price Target
$53.00
Low Price Target
$43.00
Potential Upside/Downside
+5.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.69
Trailing P/E Ratio
27.76
Forward P/E Ratio
20.79
P/E Growth
2.47
Net Income
$83.59 million
Net Margins
18.30%
Pretax Margin
23.95%
Return on Equity
14.77%
Return on Assets
8.87%

Debt

Debt-to-Equity Ratio
0.25
Current Ratio
1.61
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$1.98 billion
Price / Sales
5.28
Cash Flow
$3.22 per share
Price / Cash Flow
14.60
Book Value
$16.05 per share
Price / Book
2.93

Miscellaneous

Outstanding Shares
222,290,000
Free Float
202,285,000
Market Cap
$10.45 billion
Optionable
Optionable
Beta
0.66

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:QGEN) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners